WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+2.4%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$6.81B
AUM Growth
+$684M
(+11%)
Cap. Flow
+$636M
Cap. Flow
% of AUM
9.34%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
980
New
186
Increased
207
Reduced
145
Closed
238
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$129M |
| 2 |
Gilead Sciences
GILD
|
$114M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$92.7M |
| 4 |
Amazon
AMZN
|
$77.2M |
| 5 |
Analog Devices
ADI
|
$70.5M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$74.7M |
| 2 |
Palo Alto Networks
PANW
|
$59.8M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$55.4M |
| 4 |
Alkermes
ALKS
|
$55.3M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$53.9M |
Sector Composition
| 1 | Healthcare | 37.87% |
| 2 | Technology | 30.7% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 8.09% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBTX
901
Nanobiotix
NBTX
$408M
| – | – |
-13,009
| Closed | -$49K |
|
902
Nike
NKE
$111B
| – | – |
-77,645
| Closed | -$7.94M |
|
903
Insperity
NSP
$2.09B
| – | – |
-3,312
| Closed | -$331K |
|
904
NovoCure
NVCR
$1.32B
| – | – |
-73,925
| Closed | -$5.14M |
|
905
NXP Semiconductors
NXPI
$56.4B
| – | – |
-221,969
| Closed | -$32.9M |
|
906
Palantir
PLTR
$367B
| – | – |
-5,784,318
| Closed | -$52.5M |
|
907
ePlus
PLUS
$1.87B
| – | – |
-5,094
| Closed | -$271K |
|
908
Praxis Precision Medicines
PRAX
$963M
| – | – |
-20,583
| Closed | -$756K |
|
909
Protagonist Therapeutics
PTGX
$3.61B
| – | – |
-388,637
| Closed | -$3.07M |
|
910
Remitly
RELY
$3.99B
| – | – |
-124,017
| Closed | -$950K |
|
911
Rigel Pharmaceuticals
RIGL
$688M
| – | – |
-86,131
| Closed | -$973K |
|
912
RingCentral
RNG
$2.74B
| – | – |
-204,450
| Closed | -$10.7M |
|
913
Schrodinger
SDGR
$1.39B
| – | – |
-571,126
| Closed | -$15.1M |
|
914
Spirit AeroSystems
SPR
$4.84B
| – | – |
-1,022,658
| Closed | -$30M |
|
915
Sprout Social
SPT
$881M
| – | – |
-4,004
| Closed | -$233K |
|
916
SPDR S&P 500 ETF Trust
SPY
$659B
| – | – |
0
| – | – |
|
917
System1
SST
$56.3M
| – | – |
-1,434
| Closed | -$100K |
|
918
Teva Pharmaceuticals
TEVA
$21.3B
| – | – |
-2,040,175
| Closed | -$15.3M |
|
919
Thermo Fisher Scientific
TMO
$183B
| – | – |
-50,674
| Closed | -$27.5M |
|
920
TPG
TPG
$8.69B
| – | – |
-30,000
| Closed | -$717K |
|
921
Tourmaline Bio
TRML
$643M
| – | – |
-20,606
| Closed | -$929K |
|
922
Trane Technologies
TT
$92.3B
| – | – |
-199,052
| Closed | -$25.9M |
|
923
Twilio
TWLO
$16.1B
| – | – |
-11,049
| Closed | -$926K |
|
924
Unity
U
$16.6B
| – | – |
-8,389
| Closed | -$309K |
|
925
Upwork
UPWK
$2.22B
| – | – |
-19,045
| Closed | -$394K |
|